{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Samsung Bioepsis, Biogen, and Fujifilm Invalidate Humira® Patents in UK",
"url": "https://www.lexblog.com/2017/03/09/samsung-bioepsis-biogen-fujifilm-invalidate-humira-patents-uk/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-3APPW36Y",
"url": "https://www.lexblog.com/lib/3APPW36Y/"
},
"datePublished": "2017-03-09T21:21:57-05:00",
"dateModified": "2021-11-10T10:03:47-05:00",
"author": {
"@type": "Person",
"name": "Nicole Gifford"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Rothwell Figg"
},
"organizationScope": "at-publication",
"isPartOf": "Biosimilars Law Bulletin",
"about": "Intellectual Property",
"sourceUrl": "http://www.biosimilarsip.com/?p=3622",
"sourceStability": "may-move"
}